Is screening immigrants for latent tuberculosis cost-effective?

The Lancet Infectious Diseases

Volumn 11, Issue 6, 2011, Pages 418-419

  Mandalakas, Anna M ^a,b   Menzies, Dick ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; HUMAN; IMMIGRANT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LETTER; PATIENT SAFETY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS CONTROL; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; EMIGRANTS AND IMMIGRANTS; GREAT BRITAIN; HUMANS; LATENT TUBERCULOSIS; MASS SCREENING;

EID: 79956258329     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70102-5     Document Type: Letter

References (13)

1. Facts and figures: global estimates and trends International Organization for Migration, (accessed April 4, 2011). http://www.iom.int/jahia/Jahia/about-migration/facts-and-figures/lang/en.
2. Davies P An action plan for tuberculosis in England. J R Soc Med 2005, 98:247-248.
3. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011, 11:435-444.
4. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control National Institute for Health and Clinical Excellence, (accessed April 12, 2011). http://www.nice.org.uk/nicemedia/pdf/CG033niceguideline.pdf.
5. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 2005, 353:1008-1020.
6. Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 2003, 7(suppl 3):S384-S390.
7. Pai M, Zwerling A, Menzies D Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
8. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-γ release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (in press).
9. Metcalfe J, Everett C, Cattamanchi A, et al. Interferon-γ release assays for active pulmonary TB diagnosis in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (in press).
10. Farrant M, Grieve C, Sriskandarajah D Irregular migration in the UK 2006, Institute for Public Policy Research, London, (accessed April 12, 2011). http://www.ippr.org/publicationsandreports/publication.asp?id=446.
11. Migration statistics quarterly report Office for National Statistics, (accessed April 12, 2011). http://www.statistics.gov.uk/pdfdir/mig0211.pdf.
12. McCarthy OR Asian immigrant tuberculosis-the effect of visiting Asia. Br J Dis Chest 1984, 78:248-253.
13. Ormerod LP, Green RM, Gray S Are there still effects on Indian Subcontinent ethnic tuberculosis of return visits?: a longitudinal study 1978-97. J Infect 2001, 43:132-134.